I'm LongbridgeAI, I can summarize articles.Camp4 Therapeutics CFO Kelly Gold reported that her spouse purchased 10,000 common shares on the open market for approximately $39,600, at a weighted average price of $3.96 per share. The transaction was held indirectly through the spouse. Following this filing, Kelly Gold's direct ownership stands at 76,467 common shares.
- Camp4 Therapeutics CFO Kelly Gold reported an open-market purchase of 10,000 common shares at a weighted-average USD 3.96. * The shares were reported as held indirectly through the CFO’s spouse. * Kelly Gold also reported direct ownership of 76,467 common shares following the filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-060234), on September 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here